KM

Kanamala Mallikarjuna

Active Director Additional Director DIN 11510958
DIN 11510958 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanamala Mallikarjuna

Data last updated:

Kanamala Mallikarjuna is an Additional Director at Sriphal Life Sciences Private Limited (since 2026). The company operates in Pharma.

DIN 11510958
Primary Designation Additional Director
Industry Pharma
First Appointment 28 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director28 Jan 2026Active

Directorship timeline

Open interactive timeline →
Sriphal Life Sciences Private Limited
Premium access

Shareholding and investment profile for Kanamala Mallikarjuna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanamala Mallikarjuna

Kanamala Mallikarjuna currently holds 1 directorship: Sriphal Life Sciences Private Limited (Additional Director, since 28 Jan 2026).

Kanamala Mallikarjuna was first appointed on 28 Jan 2026 as Additional Director at Sriphal Life Sciences Private Limited.

The current boards of Kanamala Mallikarjuna's companies include Anand Nazmal Kanekanti (Sriphal Life Sciences Private Limited), Koganti Sreenivasa Rao (Sriphal Life Sciences Private Limited), Surya Bhaskar Rao Nistala (Sriphal Life Sciences Private Limited), Venkata Satyanrayana Murthy Mella (Sriphal Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available